UBV
ZVRA icon

United Bank (Virginia)’s Zevra Therapeutics ZVRA Stock Holding History

United Bank (Virginia)’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Hold
10,564
– – 0.02% 127
2026
Q1 		$98.5K Buy
+10,564
New +$95.2K 0.01% 119

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

United Bank (Virginia)'s ZVRA Position: Q2 2026 in Review

United Bank (Virginia) held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 10,564 shares worth $151K. The position accounts for 0.02% of the portfolio, ranked #127.

United Bank (Virginia) first reported a position in ZVRA in Q1 2026 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • United Bank (Virginia) held 10,564 shares of Zevra Therapeutics worth $151K as of Q2 2026.
  • United Bank (Virginia) left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up 0.02% of United Bank (Virginia)'s portfolio in Q2 2026, its #127 holding.
  • United Bank (Virginia) first reported a position in Zevra Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.